Fortrea Holdings (FTRE) EBT (2022 - 2026)
Fortrea Holdings (FTRE) reported EBT of -$12.3 million for Q1 2026, up 97.76% on a YoY basis from -$6.2 million in Q1 2025, and up 65.45% quarter-over-quarter from -$35.6 million in Q4 2025.
Fortrea Holdings (FTRE) EBT (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported EBT for 5 years, with the latest figure at -$12.3 million in Q1 2026.
- For the quarter ending Q1 2026, EBT rose 97.76% year-over-year to -$12.3 million; the trailing twelve-month figure through Mar 2026 stood at -$447.3 million (up 40.14% YoY), and the FY2025 full-year result was -$983.0 million, down 257.45% from the prior year.
- EBT for Q1 2026 stood at -$12.3 million, up from -$35.6 million in the prior quarter.
- The five-year high for EBT was $83.6 million in Q2 2022, with the low at -$548.0 million in Q1 2025.
- Historically, EBT has averaged -$72.0 million across 5 years, with a median of -$32.2 million in 2025.
- Annual changes were most pronounced in 2024 — EBT slumped 896.84% — and 2026, when it soared 97.76%.
- Fortrea Holdings' EBT stood at -$8.3 million in 2022, then sank by 559.04% to -$54.7 million in 2023, then slumped by 36.93% to -$74.9 million in 2024, then jumped by 52.47% to -$35.6 million in 2025, then surged by 65.45% to -$12.3 million in 2026.
- The last three EBT figures came in at -$12.3 million (Q1 2026), -$35.6 million (Q4 2025), and -$28.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.18 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.31 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | -12.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.30 Mn |
| Dec 31, 2025 | -35.60 Mn |
| Sep 30, 2025 | -28.70 Mn |
| Jun 30, 2025 | -370.70 Mn |
| Mar 31, 2025 | -548.00 Mn |
| Dec 31, 2024 | -74.90 Mn |
| Sep 30, 2024 | -35.80 Mn |
| Jun 30, 2024 | -88.60 Mn |
| Mar 31, 2024 | -75.70 Mn |
| Dec 31, 2023 | -54.70 Mn |
| Sep 30, 2023 | -21.90 Mn |
| Jun 30, 2023 | 36.60 Mn |
| Mar 31, 2023 | 9.50 Mn |
| Dec 31, 2022 | -8.30 Mn |
| Sep 30, 2022 | 74.20 Mn |
| Jun 30, 2022 | 83.60 Mn |